Literature DB >> 12234978

Prevention of thymic lymphoma development in Atm-/- mice by dexamethasone.

Mingshan Yan1, Xianghong Kuang, Wenan Qiang, Jianjun Shen, Kent Claypool, William S Lynn, Paul K Y Wong.   

Abstract

We have reported (M. Yan et al., FASEB J., 15: 1132-1138, 2001) that spontaneous DNA synthesisis markedly increased in the thymocytes from the atrophied thymi of young Atm-/- mice. We, therefore, set out to determine whether this elevated DNA synthesis is responsible for the development of thymic lymphomas in all Atm-/- mice by 4-5 months of age. We show here that in Atm-/- mice: (a) increased DNA synthesis occurs, especially in the immature CD4(-) CD8(-) (dominant negative) and CD8(+) thymocyte populations; (b) the relative percentage of dominant negative cells increases significantly during postnatal development, with a sharp peak at 4 weeks of age; and (c) dexamethasone suppresses DNA synthesis in these thymocytes and prevents thymic lymphoma development. These observations suggest that ataxia telangiectasia mutated (ATM) down-regulates the proliferation of thymocytes, allowing T-cell development and differentiation. The results also show that dexamethasone, like ATM, checks DNA synthesis in developing thymocytes. Finally, the data document for the first time that dexamethasone prevents or slows thymic lymphoma development in Atm-/- mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234978

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

Review 1.  Radiological imaging in ataxia telangiectasia: a review.

Authors:  Ishani Sahama; Kate Sinclair; Kerstin Pannek; Martin Lavin; Stephen Rose
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

2.  Ataxia telangiectasia mutated kinase plays a protective role in β-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling.

Authors:  Cerrone R Foster; Mahipal Singh; Venkateswaran Subramanian; Krishna Singh
Journal:  Mol Cell Biochem       Date:  2011-03-15       Impact factor: 3.396

3.  Lack of ataxia telangiectasia mutated kinase induces structural and functional changes in the heart: role in β-adrenergic receptor-stimulated apoptosis.

Authors:  Cerrone R Foster; QinQin Zha; Laura L Daniel; Mahipal Singh; Krishna Singh
Journal:  Exp Physiol       Date:  2011-12-16       Impact factor: 2.969

4.  Endoplasmic reticulum stress and unfolded protein response in Atm-deficient thymocytes and thymic lymphoma cells are attributable to oxidative stress.

Authors:  Mingshan Yan; Jianjun Shen; Maria D Person; Xianghong Kuang; William S Lynn; Daphne Atlas; Paul K Y Wong
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

5.  Experimental antioxidant therapy in ataxia telangiectasia.

Authors:  Ramune Reliene; Robert H Schiestl
Journal:  Clin Med Oncol       Date:  2008-05-20

6.  Deficiency of ataxia telangiectasia mutated kinase modulates cardiac remodeling following myocardial infarction: involvement in fibrosis and apoptosis.

Authors:  Cerrone R Foster; Laura L Daniel; Christopher R Daniels; Suman Dalal; Mahipal Singh; Krishna Singh
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

7.  MicroRNA profiling of tacrolimus-stimulated Jurkat human T lympocytes.

Authors:  Ho Kyun Lee; Sang Young Chung; Soo Jin Na Choi
Journal:  J Korean Surg Soc       Date:  2013-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.